{"id":257608,"title":"Terms of Reference: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T10:54:29.898000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/scientific-expert-advisory-panels/avastin/terms-reference-avastin-metastatic-breast-cancer.html?wbdisable=false","snippet":"Terms of Reference: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search Canada.ca…","rawSnapshotUrl":"/api/snapshots/raw/257608","browseUrl":"https://replay.healtharchive.ca/job-1/20250419105429/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/scientific-expert-advisory-panels/avastin/terms-reference-avastin-metastatic-breast-cancer.html?wbdisable=false#ha_snapshot=257608","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}